Developing an international framework for stem-cell-based embryo models
By Alfonso Martinez Arias, Nicolas Rivron, and Naomi Moris,
BioNews
| 04. 20. 2026
The ability of pluripotent stem cells to differentiate into different cell types has enabled the creation of stem-cell-based embryo models (SCBEMs), which have the potential to illuminate the early stages of embryo development and implantation. SCBEMs hold promise as an avenue to address global health challenges including infertility, pregnancy loss and the need for organ transplants, as well as congenital, neonatal and adult health conditions.
In addition to answering existing scientific questions and raising new scientific questions, SCBEMs pose practical, ethical and legal questions that also need to be addressed. Following a meeting of researchers at the Institut Pasteur in Paris in November 2024, we have been working with colleagues around the world to develop a foundational framework for research, technological development and regulation in relation to SCBEMs.
Some of our key recommendations are set out below, grouped into three sections – 'Science and standards', 'Technologies and applications' and 'Ethics and law'. These matters are explored at greater length in our full white paper, and we have also set out proposals for...
Related Articles
By Dr. Coco Newton, Progress Educational Trust | 03.30.2026
Have you ever wondered what it means to have dozens of half-siblings across the world – or to never know where half of your genetic identity comes from? A recent episode of Zembla explores the human consequences of the global...
By Marcelo Jauregui-Volpe, Wired | 04.24.2026
Two companies that launched last year with plans to create gene-edited babies have already shut down, citing money issues and internal conflict.
One of them, Manhattan Genomics of New York, closed abruptly shortly after announcing a team of scientific advisers...
By Alexandre Piquard, Le Monde [cites Katie Hasson] | 04.27.2026
"Si on en prouve la sûreté, nous croyons que l’édition préventive du génome pourrait être l’une des technologies de santé les plus importantes du siècle. » Lucas Harrington explique ainsi le but de son entreprise Preventive : créer des bébés génétiquement modifiés...
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...